156 related articles for article (PubMed ID: 29073272)
1. Highly aggressive rat prostate tumors rapidly precondition regional lymph nodes for subsequent metastatic growth.
Strömvall K; Lundholm M; Thysell E; Bergh A; Halin Bergström S
PLoS One; 2017; 12(10):e0187086. PubMed ID: 29073272
[TBL] [Abstract][Full Text] [Related]
2. Aggressive rat prostate tumors reprogram the benign parts of the prostate and regional lymph nodes prior to metastasis.
Strömvall K; Thysell E; Halin Bergström S; Bergh A
PLoS One; 2017; 12(5):e0176679. PubMed ID: 28472073
[TBL] [Abstract][Full Text] [Related]
3. Reduced number of CD169
Strömvall K; Sundkvist K; Ljungberg B; Halin Bergström S; Bergh A
Prostate; 2017 Nov; 77(15):1468-1477. PubMed ID: 28880401
[TBL] [Abstract][Full Text] [Related]
4. Extracellular Vesicles from Metastatic Rat Prostate Tumors Prime the Normal Prostate Tissue to Facilitate Tumor Growth.
Halin Bergström S; Hägglöf C; Thysell E; Bergh A; Wikström P; Lundholm M
Sci Rep; 2016 Aug; 6():31805. PubMed ID: 27550147
[TBL] [Abstract][Full Text] [Related]
5. Rat prostate tumors induce DNA synthesis in remote organs.
Halin Bergström S; Lundholm M; Nordstrand A; Bergh A
Sci Rep; 2022 May; 12(1):7908. PubMed ID: 35551231
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
[TBL] [Abstract][Full Text] [Related]
7. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
[TBL] [Abstract][Full Text] [Related]
8. Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: efficacy of flt3 ligand immunotherapy.
Somers KD; Brown RR; Holterman DA; Yousefieh N; Glass WF; Wright GL; Schellhammer PF; Qian J; Ciavarra RP
Int J Cancer; 2003 Dec; 107(5):773-80. PubMed ID: 14566827
[TBL] [Abstract][Full Text] [Related]
9. Systemic interleukin 2 therapy for human prostate tumors in a nude mouse model.
Triest JA; Grignon DJ; Cher ML; Kocheril SV; Montecillo EJ; Talati B; Tekyi-Mensah S; Pontes JE; Hillman GG
Clin Cancer Res; 1998 Aug; 4(8):2009-14. PubMed ID: 9717832
[TBL] [Abstract][Full Text] [Related]
10. Prostate stem cell antigen is overexpressed in prostate cancer metastases.
Lam JS; Yamashiro J; Shintaku IP; Vessella RL; Jenkins RB; Horvath S; Said JW; Reiter RE
Clin Cancer Res; 2005 Apr; 11(7):2591-6. PubMed ID: 15814638
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal 3.0T MRI analysis of changes in lymph node volume and apparent diffusion coefficient in an experimental animal model of metastatic and hyperplastic lymph nodes.
Klerkx WM; Geldof AA; Heintz AP; van Diest PJ; Visser F; Mali WP; Veldhuis WB
J Magn Reson Imaging; 2011 May; 33(5):1151-9. PubMed ID: 21509874
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitro.
Steiner MS; Barrack ER
Mol Endocrinol; 1992 Jan; 6(1):15-25. PubMed ID: 1738367
[TBL] [Abstract][Full Text] [Related]
13. Prediction of immune surveillance responsive metastatic prostate cancer in pelvic lymph node and emergence of surveillance unresponsive/resistant metastatic cells.
Sinha AA; Fernandes ET; Ewing SL; Wilson MJ
Anticancer Res; 2013 Sep; 33(9):3635-43. PubMed ID: 24023290
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model.
Kovar JL; Johnson MA; Volcheck WM; Chen J; Simpson MA
Am J Pathol; 2006 Oct; 169(4):1415-26. PubMed ID: 17003496
[TBL] [Abstract][Full Text] [Related]
15. Traffic to lymph nodes of PC-3 prostate tumor cells in nude mice visualized using the luciferase gene as a tumor cell marker.
Rubio N; Villacampa MM; Blanco J
Lab Invest; 1998 Oct; 78(10):1315-25. PubMed ID: 9800957
[TBL] [Abstract][Full Text] [Related]
16. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.
Pettaway CA; Pathak S; Greene G; Ramirez E; Wilson MR; Killion JJ; Fidler IJ
Clin Cancer Res; 1996 Sep; 2(9):1627-36. PubMed ID: 9816342
[TBL] [Abstract][Full Text] [Related]
17. Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction.
Deguchi T; Doi T; Ehara H; Ito S; Takahashi Y; Nishino Y; Fujihiro S; Kawamura T; Komeda H; Horie M
Cancer Res; 1993 Nov; 53(22):5350-4. PubMed ID: 7693338
[TBL] [Abstract][Full Text] [Related]
18. Number of metastatic lymph nodes as determinant of outcome after salvage radical prostatectomy for radiation-recurrent prostate cancer.
Gugliemetti G; Sukhu R; Conca Baenas MA; Meeks J; Sjoberg DD; Eastham JA; Scardino PT; Touijer K
Actas Urol Esp; 2016 Sep; 40(7):434-9. PubMed ID: 27184342
[TBL] [Abstract][Full Text] [Related]
19. Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis.
Burton JB; Priceman SJ; Sung JL; Brakenhielm E; An DS; Pytowski B; Alitalo K; Wu L
Cancer Res; 2008 Oct; 68(19):7828-37. PubMed ID: 18829538
[TBL] [Abstract][Full Text] [Related]
20. Extratumoral Heme Oxygenase-1 (HO-1) Expressing Macrophages Likely Promote Primary and Metastatic Prostate Tumor Growth.
Halin Bergström S; Nilsson M; Adamo H; Thysell E; Jernberg E; Stattin P; Widmark A; Wikström P; Bergh A
PLoS One; 2016; 11(6):e0157280. PubMed ID: 27280718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
